Menu ×


Immunotherapy Drug Market : Global Demand Analysis & Opportunity Outlook 2021

  • Report ID: 60
  • Text Size:

Extensive insights into the Growth of Immunotherapy Drug Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

Immunotherapy Drug Overview

Immunotherapy also referred as biologic therapy is a kind of treatment which is designed to enhance human immunity system to fight against cancer. Immunotherapy restores or improves immunity system to restrict growth of cancer cells, preventing it to spread to other parts of the body and also enables the immunity system to destroy cancer cells from the body.   

Global Immunotherapy Drug market is envisioned to exhibit a compound annual growth rate (CAGR) of 13.0% during 2015-2021.

Market Size and Forecast

North America is believed to hold the first rank in global immunotherapy drug market during 2015-2021. It is projected that in 2016, 1.7 million new cancer cases would be detected in the U.S., making the country a major market for immunotherapy drugs in North America. The immunotherapy drug market in the region is also believed to spurt from higher spending on health care sector.Western Europe immunotherapy drug market is also expected to witness a promising growth sparked by rising cases of lung cancer, which is responsible for 215 of all cancer mortalities in the European region.Asia-Pacific immunotherapy drug market is likely to behold the highest CAGR during the forecast period i.e. 2015-2021. Rising per capita income and increasing investments on healthcare infrastructure are some of the major factors which are projected to bolster Immunotherapy Drug market in countries such as India and China. CLICK TO DOWNLOAD FREE SAMPLE

Market Segmentation

By Drug Types

Based on types, global Immunotherapy Drug market can be segmented into:

  • Antibodies
  • Interleukins
  • Interferon
  • Checkpoint Inhibitors
  • Vaccines

By Region

  • North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Growth Drivers and challenges

Rising incidences of cancer across the globe coupled with increasing inclination towards cancer treatments with lesser side effects are believed to augment the growth of global immunotherapy drug market in future.

In addition to that, escalation of approval process in cancer related drugs is also expected to drive the global immunotherapy drug market over the forecast period i.e. 2015-2021.

However, high cost associated with immunotherapy devices along with lack of awareness of biologic cancer therapy is anticipated to hamper the growth of global immunotherapy drug market over next few years.

Key Players

Global Immunotherapy Drug market includes some of the major players such as AbbVie Inc., Amgen Inc., Novartis International Ag, F. Hoffmann-La Roche Ltd, Merck, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, AstraZeneca plc, Pfizer Inc.


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved